Abstract
Background Testing recommendations for COVID-19 in the United States varied by state and over time in the spring and summer of 2020.
Methods We compiled data about COVID-19 testing, cases, and deaths, and excess pneumonia + influenza + COVID-19 deaths to assess relationships between testing recommendations, per capita tests performed, epidemic intensity, and excess mortality during the early phase of the COVID-19 pandemic in the United States.
Results As of July 2020, 16 states recommended testing asymptomatic members of the general public. The rate of COVID-19 tests reported in each state correlates with more inclusive testing recommendations and with higher epidemic intensity. Higher per capita testing was associated with more complete reporting of COVID-19 deaths, which is a fundamental requirement for analyzing the pandemic.
Conclusions Reported deaths due to COVID-19 likely represent an undercount of the true burden of the pandemic. Coordinated, consistent guidelines for COVID-19 testing should be a high priority for state and national health systems.
Competing Interest Statement
SRP has received travels fees from Pfizer for work unrelated to this manuscript. DMW has received consulting fees from Pfizer, Merck, GSK, and Affinivax for work unrelated to this manuscript and is Principal Investigator on a grant from Pfizer to Yale University on a project unrelated to this manuscript.
Funding Statement
No external funding was received in support of this work. SP was supported by a NIH T32 grant, 2T32AI007210-36A1 (MPI)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yale University Institutional Review Board Federalwide Assurance FWA#00002571 Expiration Date, January 5, 2022
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The discussion was updated to clarify context of analyses. Alternative approaches to modeling the impact of state-level recommendations on the number of tests performed, and the impact of the number of tests performed on the completeness of mortality data were added.
Data Availability
All data and sources are included in this manuscript.
List of Abbreviations
- PIC
- pneumonia + influenza + COVID-19
- CI
- confidence interval
